A detailed history of J.P. Marvel Investment Advisors, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, J.P. Marvel Investment Advisors, LLC holds 40,350 shares of MRK stock, worth $4.43 Million. This represents 0.82% of its overall portfolio holdings.

Number of Shares
40,350
Previous 40,350 -0.0%
Holding current value
$4.43 Million
Previous $5.32 Million 6.18%
% of portfolio
0.82%
Previous 0.92%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 13, 2024

SELL
$100.18 - $109.02 $16,028 - $17,443
-160 Reduced 0.39%
40,350 $4.4 Million
Q4 2022

Jan 18, 2023

SELL
$87.44 - $112.11 $5,246 - $6,726
-60 Reduced 0.15%
40,510 $0
Q3 2022

Oct 24, 2022

SELL
$84.53 - $94.96 $1,859 - $2,089
-22 Reduced 0.05%
40,570 $3.49 Million
Q3 2021

Nov 15, 2021

BUY
$71.68 - $78.83 $1,576 - $1,734
22 Added 0.05%
40,592 $3.05 Million
Q2 2021

Sep 09, 2021

BUY
$70.31 - $77.77 $77,341 - $85,547
1,100 Added 2.79%
40,570 $3.16 Million
Q3 2020

Sep 09, 2021

SELL
$73.18 - $82.95 $9,513 - $10,783
-130 Reduced 0.33%
39,470 $3.27 Million
Q2 2020

Sep 09, 2021

SELL
$70.42 - $80.13 $7,042 - $8,013
-100 Reduced 0.25%
39,600 $3.06 Million
Q1 2020

Sep 09, 2021

SELL
$63.36 - $87.82 $13,939 - $19,320
-220 Reduced 0.55%
39,700 $3.06 Million
Q3 2019

Nov 20, 2019

SELL
$76.08 - $82.93 $15,976 - $17,415
-210 Reduced 0.52%
39,920 $3.36 Million
Q1 2019

May 16, 2019

SELL
$69.58 - $79.36 $8,349 - $9,523
-120 Reduced 0.3%
40,130 $3.34 Million
Q4 2018

Feb 13, 2019

SELL
$65.24 - $75.71 $30,010 - $34,826
-460 Reduced 1.13%
40,250 $3.08 Million
Q3 2017

Nov 13, 2017

SELL
$58.67 - $63.13 $32,855 - $35,352
-560 Reduced 1.36%
40,710 $2.61 Million
Q2 2017

Aug 24, 2017

BUY
N/A
41,270
41,270 $2.65 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $278B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track J.P. Marvel Investment Advisors, LLC Portfolio

Follow J.P. Marvel Investment Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of J.P. Marvel Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on J.P. Marvel Investment Advisors, LLC with notifications on news.